Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT02575456
Eligibility Criteria:
Inclusion Criteria:
* Aged between 18 and 50 years
* Able to understand the content of informed consent and signed the informed consent
* Able and willing to complete all the secluded study process during the whole study follow-up period (about 6 months).
* Negative in HIV diagnostic blood test on day of enrollment
* Axillary temperature ≤37.0°C on the day of enrollment
* Non-pregnant females with a negative result in the urine pregnancy test on day of enrollment
* General good health as established by medical history and physical examination.
Exclusion Criteria:
* Infected by Ebola virus (inquiry)
* Vaccination with other Ebola vaccine (inquiry)
* HIV infection or other serious immunodeficiency disease (inquiry)
* Allergic history of any vaccination or drugs, or allergic to any ingredient of the Ad5-EBOV, such as mannitol
* Family history of brain or mental disease
* Woman who is pregnant or breast-feeding
* Any acute fever disease or infections in last 7 days
* Major congenital defects or not well-controlled chronic illness
* Asplenia or functional asplenia
* Platelet disorder or other bleeding disorder
* Faint at the sight of blood or needles.
* Prior administration of immunodepressant or corticosteroids, antianaphylaxis treatment, cytotoxic treatment in last 6 months
* Prior administration of other research medicines in last 1 month
* Prior administration of attenuated vaccine(s) in the last one month
* Prior administration of inactivated vaccine(s) in the last 14 days
* Any condition that in the opinion of the investigators may interfere with the participants' compliance or evaluation of study objectives
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
50 Years
Study:
NCT02575456
Study Brief:
Protocol Section:
NCT02575456